diff --git a/Pa. Medicaid Ends Adult Coverage of GLP-1s for Weight Loss.-.md b/Pa. Medicaid Ends Adult Coverage of GLP-1s for Weight Loss.-.md new file mode 100644 index 0000000..686507f --- /dev/null +++ b/Pa. Medicaid Ends Adult Coverage of GLP-1s for Weight Loss.-.md @@ -0,0 +1,9 @@ +
Effective January 1, 2026, Pennsylvania Medicaid will no longer cover GLP-1 medications when prescribed for weight loss for adults age 21 and over. GLP-1s are medications approved to treat several conditions, including weight loss, type 2 diabetes, and other health issues. Common brand names include Wegovy, Saxenda, Zepbound, Ozempic, Mounjaro, Victoza, and Trulicity. Important: Everyone taking a GLP-1 must take action, even if this coverage change doesn't affect you. According to recent DHS guidance, anyone who wants to continue their GLP-1 past December 31, 2025 must have their doctor request a new authorization-including people under 21 and those taking GLP-1s for reasons other than weight loss. Who Can Still Get GLP-1s After January 1? 1. Children and young adults under 21 may still receive GLP-1s for weight loss or to treat overweight/obesity. Federal law requires Medicaid to cover all medically necessary treatments for people under 21, even when those treatments aren't available to adults. This requirement is called Early and Periodic Screening, Diagnosis and Treatment (EPSDT).
+ +
2. Adults prescribed a GLP-1 for other conditions may still qualify if they meet prior authorization requirements. Remember: Children under 21 and adults must ask their doctors to submit a new prior authorization [request](https://www.behance.net/search/projects/?sort=appreciations&time=week&search=request) before January 1, 2026 to avoid a gap in coverage. What Should You Do Now? Everyone taking a GLP-1 paid for by Medicaid has by now received a letter stating that coverage for their medication ends on December 31, 2025. This letter was sent regardless of age or reason for taking the medication. Appeal the letter by requesting a complaint or grievance through your Medicaid HealthChoices plan. Your plan cannot discourage or refuse to accept this request. Ask your doctor to submit a new prior authorization request with a start date of January 1, 2026. If this request is also denied, appeal that denial too. Timing matters: If you request an appeal within 15 days of the date on the letter, your GLP-1 coverage should continue during the appeal process. If you appeal after that deadline but on or before December 31, 2025, coverage may or may not continue during the appeal. Appeal early and document when you submitted your request. If you are under age 21 and your Medicaid plan denies a GLP-1 saying the medication isn't covered for weight loss, appeal the denial. Under EPSDT, a Medicaid plan cannot simply say GLP-1s aren't covered for weight loss or obesity for people under 21. Instead, the plan must determine whether the GLP-1 is medically necessary to treat your condition and, if they decide the medication isn't medically necessary, they must explain why. If they haven't done this, you should appeal.
+ +
Science continues to prove that the old adage "you are what you eat" is profoundly true. This is because you have trillions of microorganisms living in your gut, which are directly responsible [supplement for a balanced lifestyle](https://rentry.co/47026-glp-weight-loss-a-revolutionary-approach-to-obesity-management) nearly every aspect of your health. These microbes make up what’s called your "gut microbiota." They are especially influential in determining your likelihood of gaining excessive weight, becoming obese, and developing obesity-related diseases like diabetes, heart disease, and premature death. The gut microbiome (the expressed genes of your gut microbiota) plays a major role in your metabolism through energy production, storage, and [daily wellness supplement](http://cgi.www5b.biglobe.ne.jp/~akanbe/yu-betsu/joyful/joyful.cgi?page=20) expenditure. So, it’s no surprise that science has found a strong connection between gut microbiome imbalance and metabolic syndrome. Yikes! If you have the wrong mix of microbes, it could be making it tough for you to get your health on track! Did you know: Scientists can actually look at your gut microbiome composition and tell with 90% accuracy if you are obese or lean. That’s pretty impressive, isn’t it?
+ +
1. Unable to lose weight and keep it off? 2. Struggling to fight cravings? 3. Sick of starving yourself for weight loss? 4. Baffled as to why no diet seems to really work for you? [Depending](https://www.deer-digest.com/?s=Depending) on the composition of your gut microbiome, your microbes can either boost your health or weigh you down (figuratively and literally). The good news is this: You have control over these little guys with every bite you eat. Diet has the power to change the landscape of your gut microbiome. So, if you’ve tried multiple diets and can’t seem to get the results you want, it’s time to look into your gut microbiome.Will You Lose Weight Naturally on an Individualized Diet? If you’ve been struggling to lose weight and keep it off - it could be your gut microbiome. While Viome doesn’t guarantee weight loss, it has been an exciting result many of our customers have reported. "Fiona’s update day 37!
+ +
We know weight loss can be tough. Find out if your weight struggles are due to a gut microbiome imbalance with Viome - and let’s tip the scales in your favor. Your gut microbes actually digest much of your food for you. When your gut microbiota help digest your food, they turn it into nutrients, neurotransmitters, vitamins, hormones, and more. Through these metabolites, the composition of your gut microbiome influences nearly every metabolic activity. It’s accurate to think of your gut microbiome as an organ that’s part immune system and part energy regulator. If your gut microbiome is imbalanced, certain bacteria end up working to protect themselves from the harsh environment and are not able to help you. In the worst case scenario, you can have microbiota adding to your health problems, making it harder for you to get healthy and lose weight. Viome’s metatranscriptomic technology has allowed us identify microbial pathways and functions, specifically those that influence weight loss or gain.
\ No newline at end of file